First-in-Human Study for Novel, Inhaled, Lung-Selective pan-Janus Kinase (JAK) Inhibitor with Potentially Broad Activity Across Range of Serious Respiratory Diseases
PR Newswire
DUBLIN, Nov. 27, 2018
PR Newswire
DUBLIN, Nov. 27, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey